COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

28,998 Articles (21,508 medRxiv, 7,490 bioRxiv)

Most recent first Previous |  Page 38: Articles 371-380  | Next

Impact of Shifting University Policies During the COVID-19 Pandemic on Self-Reported Employee Social Networks
Johnson, S. S., Jackson, K. C., Lofgren, E. T.
10.1101/2024.02.08.24302489 — Posted: 2024-02-08
Discovering and overcoming the bias in neoantigen identification by unified machine learning models
Zhang, Z., Wu, W., Wei, L., Wang, X.
10.1101/2024.02.07.579420 — Posted: 2024-02-08
Traditional uses and pharmacological activities of Tetracera alnifolia (Wild) Drake
Camara, A. K., Balde, E. S., Diallo, M. S. T., Camara, M. K., Bah, T. V., Conde, M., Soumah, A., Tietjen, I., Balde, A. M.
10.1101/2024.02.07.579282 — Posted: 2024-02-08
Dimensionality reduction distills complex evolutionary relationships in seasonal influenza and SARS-CoV-2
Nanduri, S., Black, A., Bedford, T., Huddleston, J.
10.1101/2024.02.07.579374 — Posted: 2024-02-08
Science Education for the Youth (SEFTY): A Neuroscience Outreach Program for High School Students in Southern Nevada During the COVID-19 Pandemic
Ghani, N., Baker, H., Huntsinger, A., Chen, T., Familara, T. D., Itorralba, J. Y., Vanderford, F., Zhuang, X., Chang, C.-L., Vo, V., Oh, E.
10.1101/2024.02.02.578716 — Posted: 2024-02-07
Is SARS-CoV-2 elimination or mitigation best? Regional and disease characteristics determine the recommended strategy
Martignoni, M. M., Arino, J., Hurford, A. M.
10.1101/2024.02.01.24302169 — Posted: 2024-02-07
Heterogeneity of Diagnosis and Documentation of Post-COVID Conditions in Primary Care: A Machine Learning Analysis
Hendrix, N., Parikh, R. V., Taskier, M., Walter, G., Rochlin, I., Saydeh, S., Koumans, E. H., Rincon-Guevara, O., Rehkopf, D. H., Phillips, R. L.
10.1101/2024.02.07.24302451 — Posted: 2024-02-07
SARS-CoV-2 infection elucidates unique features of pregnancy-specific immunity
Oh, D. S., Kim, E., Lu, G., Normand, R., Shook, L. L., Lyall, A., Jasset, O., Demidkin, S., Gilbert, E., Kim, J., Akinwunmi, B., Tantivit, J., Tirard, A., Arnold, B. Y., Slowikowski, K., MGH COVID-19 Collection & Processing Team, , Goldberg, M. B., Filbin, M. R., Hacohen, N., Nguyen, L. H., Chan, A. T., Yu, X. G., Li, J. Z., Yonker, L., Fasano, A., Perlis, R. H., Pasternak, O., Gray, K. J., Choi, G. B., Drew, D. A., Sen, P., Villani, A.-C., Edlow, A. G., Huh, J. R.
10.1101/2024.02.05.24301794 — Posted: 2024-02-07
Acute kidney injury outcomes of COVID-19 confirmed patients in a Philippine tertiary hospital: A retrospective study
Sayson, J., Kalaw, R., Ordona, B. E., Lim, M. E.
10.1101/2024.02.05.24302369 — Posted: 2024-02-06
SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series
Korosec, C. S., Dick, D. W., Moyles, I., Watmough, J.
10.1101/2024.02.06.24302345 — Posted: 2024-02-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).